| scholarly article | Q13442814 |
| P2093 | author name string | David J Margolis | |
| William D James | |||
| John S Barbieri | |||
| Natalie Spaccarelli | |||
| P2860 | cites work | Adult female acne treated with spironolactone: a retrospective data review of 70 cases | Q38598246 |
| Laboratory Monitoring During Isotretinoin Therapy for Acne: A Systematic Review and Meta-analysis | Q38656836 | ||
| The Clinical Relevance of Antibiotic Resistance: Thirteen Principles That Every Dermatologist Needs to Consider When Prescribing Antibiotic Therapy | Q38789211 | ||
| Safety Considerations and Monitoring in Patients Treated with Systemic Medications for Acne | Q38789213 | ||
| Spironolactone for the Treatment of Acne: A 4-Year Retrospective Study | Q38803716 | ||
| U.S. Medical Eligibility Criteria for Contraceptive Use, 2016. | Q38911038 | ||
| Isotretinoin treatment for acne and risk of depression: A systematic review and meta-analysis | Q39177755 | ||
| Patterns of antimicrobial resistance in lesions of hidradenitis suppurativa | Q39290562 | ||
| Anti-acne drugs in phase 1 and 2 clinical trials | Q39382177 | ||
| Isotretinoin and Timing of Procedural Interventions: A Systematic Review With Consensus Recommendations | Q39402808 | ||
| Trends in prescribing behavior of systemic agents used in the treatment of acne among dermatologists and nondermatologists: A retrospective analysis, 2004-2013. | Q40135355 | ||
| Long-term use of antibiotics and risk of colorectal adenoma | Q40257973 | ||
| New progestogens in oral contraception | Q40730425 | ||
| Staphylococcus aureus carriage rates and antibiotic resistance patterns in patients with acne vulgaris | Q40829806 | ||
| Duration of oral antibiotic therapy for the treatment of adult acne: a retrospective analysis investigating adherence to guideline recommendations and opportunities for cost-savings | Q41265046 | ||
| Oral isotretinoin. How can we treat difficult acne patients? | Q41601909 | ||
| Effect of low-dose oral contraceptives on androgenic markers and acne. | Q41724983 | ||
| Spironolactone directly inhibits proliferation of cultured human facial sebocytes and acts antagonistically to testosterone and 5 alpha-dihydrotestosterone in vitro | Q42511834 | ||
| Low-cumulative dose isotretinoin treatment in mild-to-moderate acne: efficacy in achieving stable remission | Q42685036 | ||
| Effects of oral contraceptives containing ethinylestradiol with either drospirenone or levonorgestrel on various parameters associated with well-being in healthy women: a randomized, single-blind, parallel-group, multicentre study | Q43103057 | ||
| Antibiotic use in relation to the risk of breast cancer | Q43622802 | ||
| Thrombotic stroke and myocardial infarction with hormonal contraception | Q43828053 | ||
| A retrospective analysis of the duration of oral antibiotic therapy for the treatment of acne among adolescents: investigating practice gaps and potential cost-savings. | Q44025850 | ||
| The effect of 2 combined oral Contraceptives containing either drospirenone or cyproterone acetate on acne and seborrhea | Q44049658 | ||
| Effect of Antibiotics on the Oropharyngeal Flora in Patients With Acne | Q44411252 | ||
| High-dose isotretinoin treatment and the rate of retrial, relapse, and adverse effects in patients with acne vulgaris | Q44544553 | ||
| Systematic review of Propionibacterium acnes resistance to systemic antibiotics. | Q44847162 | ||
| Complementary therapies for acne vulgaris | Q24186578 | ||
| Combined oral contraceptives: venous thrombosis | Q24198113 | ||
| Combined oral contraceptive pills for treatment of acne | Q24202713 | ||
| Spironolactone versus placebo or in combination with steroids for hirsutism and/or acne | Q24241760 | ||
| Isotretinoin use and the risk of inflammatory bowel disease: a case-control study | Q24621195 | ||
| Acne Treatment Based on Selective Photothermolysis of Sebaceous Follicles with Topically Delivered Light-Absorbing Gold Microparticles | Q27022299 | ||
| Prevalence of Inappropriate Antibiotic Prescriptions Among US Ambulatory Care Visits, 2010-2011 | Q28005532 | ||
| Guidelines of care for the management of acne vulgaris | Q28071588 | ||
| Past oral contraceptive use and angiographic coronary artery disease in postmenopausal women: data from the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation | Q28196401 | ||
| European recommendations on the use of oral antibiotics for acne | Q28295165 | ||
| Isotretinoin and risk for inflammatory bowel disease: a nested case-control study and meta-analysis of published and unpublished data | Q30591549 | ||
| The role of pulsed light and heat energy (LHE) in acne clearance | Q30763805 | ||
| Pulsed-dye laser treatment for inflammatory acne vulgaris: randomised controlled trial | Q31019677 | ||
| Acne treatment with a 1,450 nm wavelength laser and cryogen spray cooling | Q31107922 | ||
| Cancer risk among users of oral contraceptives: cohort data from the Royal College of General Practitioner's oral contraception study | Q31128167 | ||
| Risk of hyperkalemia in women taking ethinylestradiol/drospirenone and other oral contraceptives | Q33156749 | ||
| Treatment of inflammatory facial acne vulgaris with the 1450-nm diode laser: a pilot study | Q33197321 | ||
| 420 nm intense continuous light therapy for acne | Q33208980 | ||
| Cutaneous immunological activation elicited by a low-fluence pulsed dye laser | Q33226925 | ||
| Combination blue (415 nm) and red (633 nm) LED phototherapy in the treatment of mild to severe acne vulgaris | Q33246395 | ||
| The 1450-nm diode laser for facial inflammatory acne vulgaris: dose-response and 12-month follow-up study | Q33247094 | ||
| Pulsed dye laser treatment of acne. Study of clinical efficacy and mechanism of action | Q33292514 | ||
| Acne vulgaris: lasers, light sources and photodynamic therapy--an update 2007. | Q33307189 | ||
| Phototherapy in the treatment of acne vulgaris. | Q33355787 | ||
| Clinical effect of low-energy double-pass 1450 nm laser treatment for acne in Asians | Q33400828 | ||
| Double-pass, low-fluence laser treatment using a large spot-size 1,450 nm laser improves acne | Q33410415 | ||
| Photopneumatic therapy for the treatment of acne. | Q33416067 | ||
| Whey protein precipitating moderate to severe acne flares in 5 teenaged athletes | Q84988857 | ||
| Comparison of desogestrel/ethinyl estradiol plus spironolactone versus cyproterone acetate/ethinyl estradiol in the treatment of polycystic ovary syndrome: a randomized controlled trial | Q85801816 | ||
| Role of the combination spironolactone-norgestimate-estrogen in Hirsute women with polycystic ovary syndrome | Q85831099 | ||
| Making sense of the effects of the cumulative dose of isotretinoin in acne vulgaris | Q86494631 | ||
| Propionibacterium acnes promotes Th17 and Th17/Th1 responses in acne patients | Q87378147 | ||
| Dairy intake and acne development: A meta-analysis of observational studies | Q88736787 | ||
| Comparison of efficacy of aminolaevulinic acid photodynamic therapy vs. adapalene gel plus oral doxycycline for treatment of moderate acne vulgaris-A simple, blind, randomized, and controlled trial | Q89546271 | ||
| Advances in Acne and Rosacea Therapy | Q91328811 | ||
| Frequency of Treatment Switching for Spironolactone Compared to Oral Tetracycline-Class Antibiotics for Women With Acne: A Retrospective Cohort Study 2010-2016 | Q95577615 | ||
| New insights into the management of acne: an update from the Global Alliance to Improve Outcomes in Acne group | Q33431703 | ||
| Standardized laboratory monitoring with use of isotretinoin in acne | Q33432302 | ||
| Role of the 585-nm pulsed dye laser in the treatment of acne in comparison with other topical therapeutic modalities | Q33434569 | ||
| Intense pulsed light (IPL): a review | Q33532212 | ||
| The pulsed-dye laser as an adjuvant treatment modality in acne vulgaris: a randomized controlled single-blinded trial | Q33556148 | ||
| Spironolactone for the treatment of acne in women, a retrospective study of 110 patients | Q33715142 | ||
| Phototherapy with blue (415 nm) and red (660 nm) light in the treatment of acne vulgaris | Q33901813 | ||
| Phenotypic and genotypic characterization of antibiotic-resistant Propionibacterium acnes isolated from acne patients attending dermatology clinics in Europe, the U.S.A., Japan and Australia | Q33938273 | ||
| Ischemic stroke risk with oral contraceptives: A meta-analysis | Q33953321 | ||
| Acne vulgaris: a disease of Western civilization | Q33963012 | ||
| Evaluation of the clinical efficacy of the 1,450 nm laser in acne vulgaris: a randomized split-face, investigator-blinded clinical trial | Q34016985 | ||
| An analysis of reports of depression and suicide in patients treated with isotretinoin | Q34092291 | ||
| The association between drospirenone and hyperkalemia: a comparative-safety study | Q34114759 | ||
| Cortexolone 17α-propionate 1% cream, a new potent antiandrogen for topical treatment of acne vulgaris. A pilot randomized, double-blind comparative study vs. placebo and tretinoin 0·05% cream | Q34172715 | ||
| Pathways to inflammation: acne pathophysiology | Q34187125 | ||
| Management of acne: a report from a Global Alliance to Improve Outcomes in Acne. | Q34209858 | ||
| Retinoic acid and affective disorders: the evidence for an association | Q34214697 | ||
| Association of suicide attempts with acne and treatment with isotretinoin: retrospective Swedish cohort study | Q34300022 | ||
| High glycemic load diet, milk and ice cream consumption are related to acne vulgaris in Malaysian young adults: a case control study | Q34381936 | ||
| Uses and complications of isotretinoin therapy | Q34405220 | ||
| Meta-analysis comparing efficacy of antibiotics versus oral contraceptives in acne vulgaris. | Q34422175 | ||
| Acne pathogenesis: history of concepts | Q34439039 | ||
| Recent advances in acne pathogenesis: implications for therapy | Q34447463 | ||
| Diet in dermatology: Part I. Atopic dermatitis, acne, and nonmelanoma skin cancer | Q34451099 | ||
| Low Usefulness of Potassium Monitoring Among Healthy Young Women Taking Spironolactone for Acne. | Q34468098 | ||
| Systematic review of antibiotic resistance in acne: an increasing topical and oral threat | Q34512706 | ||
| Spironolactone use and risk of incident cancers: a retrospective, matched cohort study | Q34542518 | ||
| Oral Spironolactone for Acne Vulgaris in Adult Females: A Hybrid Systematic Review | Q34550556 | ||
| High school dietary dairy intake and teenage acne | Q34554810 | ||
| Implications for the role of diet in acne | Q34560004 | ||
| Tolerance of spironolactone | Q34563463 | ||
| Low-dose isotretinoin in the treatment of acne vulgaris | Q34565771 | ||
| Isotretinoin therapy and the incidence of acne relapse: a nested case-control study | Q34584358 | ||
| Milk consumption and acne in teenaged boys | Q34587075 | ||
| Acne vulgaris related to androgens - a review | Q38192472 | ||
| Antibiotic stewardship in dermatology: limiting antibiotic use in acne | Q38203719 | ||
| Treatment of facial acne papules and pustules in Korean patients using an intense pulsed light device equipped with a 530- to 750-nm filter | Q38505636 | ||
| Low-dose oral contraceptive use and the risk of myocardial infarction. | Q44871739 | ||
| Mediterranean diet and familial dysmetabolism as factors influencing the development of acne | Q44879558 | ||
| Superiority of a combined contraceptive containing drospirenone to a triphasic preparation containing norgestimate in acne treatment | Q45066989 | ||
| Acne and milk, the diet myth, and beyond | Q45251647 | ||
| Antibiotic-resistant Propionibacterium acnes among acne patients in a regional skin centre in Hong Kong | Q45341360 | ||
| Glycemic index, glycemic load, wellness and beauty: the state of the art. | Q45738206 | ||
| Isotretinoin is not associated with inflammatory bowel disease: a population-based case-control study. | Q45923603 | ||
| Isotretinoin Laboratory Test Monitoring--A Call to Decrease Testing in an Era of High-Value, Cost-Conscious Care | Q46279654 | ||
| Treatment of acne using a 3-milligram drospirenone/20-microgram ethinyl estradiol oral contraceptive administered in a 24/4 regimen: a randomized controlled trial | Q46338567 | ||
| Antibiotic treatment of acne may be associated with upper respiratory tract infections | Q46711466 | ||
| Efficacy and tolerance of acne treatment using both spironolactone and a combined contraceptive containing drospirenone | Q46928292 | ||
| Contemporary Hormonal Contraception and the Risk of Breast Cancer. | Q47277235 | ||
| Suicidal Ideation, Mental Health Problems, and Social Impairment Are Increased in Adolescents with Acne: A Population-Based Study | Q48791757 | ||
| Comparing the Efficacy of Low Dose and Conventional Dose of Oral Isotretinoin in Treatment of Moderate and Severe Acne Vulgaris | Q49231947 | ||
| Acne phototherapy with a high-intensity, enhanced, narrow-band, blue light source: an open study and in vitro investigation. | Q50497449 | ||
| Norgestimate and ethinyl estradiol in the treatment of acne vulgaris: a randomized, placebo-controlled trial. | Q50965416 | ||
| Dietary glycemic factors, insulin resistance, and adiponectin levels in acne vulgaris. | Q51286141 | ||
| Hormonal Contraceptives and Acne: A Retrospective Analysis of 2147 Patients. | Q51301179 | ||
| Dietary glycemic index and glucose, insulin, insulin-like growth factor-I, insulin-like growth factor binding protein 3, and leptin levels in patients with acne. | Q51467020 | ||
| Anti-androgenic therapy using oral spironolactone for acne vulgaris in Asians. | Q51778249 | ||
| Isotretinoin treatment in patients with acne vulgaris: does it impact muscle strength, fatigue, and endurance? | Q51820713 | ||
| The Use of Hormonal Antiandrogen Therapy in Female Patients with Acne: A 10-Year Retrospective Study. | Q52647296 | ||
| Effect of drospirenone on serum potassium and drospirenone pharmacokinetics in women with normal or impaired renal function. | Q52931658 | ||
| Isotretinoin exposure and risk of inflammatory bowel disease. | Q53084367 | ||
| Clinical and histological effect of a low glycaemic load diet in treatment of acne vulgaris in Korean patients: a randomized, controlled trial. | Q53372858 | ||
| Effectiveness of conventional, low-dose and intermittent oral isotretinoin in the treatment of acne: a randomized, controlled comparative study. | Q53449369 | ||
| Results of a Phase 2, Randomized,Vehicle-Controlled Study Evaluating the Efficacy,Tolerability, and Safety of Daily or Twice Daily SB204 for the Treatment of Acne Vulgaris. | Q53533383 | ||
| Antibiotic Resistance in Acne Treatment. | Q53735748 | ||
| Bacterial resistance and therapeutic outcome following three months of topical acne therapy with 2% erythromycin gel versus its vehicle. | Q53956937 | ||
| Milk consumption and acne in adolescent girls. | Q55042668 | ||
| A low-glycemic-load diet improves symptoms in acne vulgaris patients: a randomized controlled trial. | Q55044166 | ||
| Spironolactone use and the risk of breast and gynecologic cancers. | Q55057491 | ||
| Oral spironolactone improves acne vulgaris and reduces sebum excretion | Q55062432 | ||
| Is Oral Omega-3 Effective in Reducing Mucocutaneous Side Effects of Isotretinoin in Patients with Acne Vulgaris? | Q55554943 | ||
| Milk consumption: aggravating factor of acne and promoter of chronic diseases of Western societies | Q56601583 | ||
| European evidence-based (S3) guideline for the treatment of acne - update 2016 - short version | Q56962143 | ||
| Probable Migraine With Visual Aura and Risk of Ischemic Stroke | Q57437289 | ||
| Comparison of flutamide and spironolactone in the treatment of hirsutism: a randomized controlled trial**Supported in part by Schering-Plough, Pointe-Claire, Québec, Canada | Q59831343 | ||
| A prospective study of past use of oral contraceptive agents and risk of cardiovascular diseases | Q67959874 | ||
| Ocular side effects of isotretinoin therapy | Q68092005 | ||
| Oral spironolactone: an effective treatment for acne vulgaris in women | Q70009159 | ||
| Disturbances in sexual differentiation of rat foetuses following spironolactone treatment | Q71459993 | ||
| Use and misuse of oral contraceptives: risk indicators for poor pill taking and discontinuation | Q71939893 | ||
| Low-dose adjunctive spironolactone in the treatment of acne in women: a retrospective analysis of 85 consecutively treated patients | Q74212716 | ||
| Recurrence rates after the first course of isotretinoin | Q74375549 | ||
| The effect of a low glycemic load diet on acne vulgaris and the fatty acid composition of skin surface triglycerides | Q80452434 | ||
| Upper respiratory tract infection in household contacts of acne patients | Q81153221 | ||
| Treatment of moderate acne vulgaris using a combined oral contraceptive containing ethinylestradiol 20 μg plus drospirenone 3mg administered in a 24/4 regimen: a pooled analysis | Q83355056 | ||
| Ocular adverse effects of systemic treatment with isotretinoin | Q83906461 | ||
| Effect of smooth pulsed light at 400 to 700 and 870 to 1,200 nm for acne vulgaris in Asian skin | Q84899118 | ||
| Role of insulin, insulin-like growth factor-1, hyperglycaemic food and milk consumption in the pathogenesis of acne vulgaris | Q34611221 | ||
| The effect of a high-protein, low glycemic-load diet versus a conventional, high glycemic-load diet on biochemical parameters associated with acne vulgaris: a randomized, investigator-masked, controlled trial | Q34621172 | ||
| Potential association between the oral tetracycline class of antimicrobials used to treat acne and inflammatory bowel disease | Q34622394 | ||
| Nutrition and acne | Q34624872 | ||
| European evidence-based (S3) guidelines for the treatment of acne. | Q34636056 | ||
| Relationships of self-reported dietary factors and perceived acne severity in a cohort of New York young adults | Q34658827 | ||
| Spironolactone and cimetidine in treatment of acne | Q34659429 | ||
| Does exposure to isotretinoin increase the risk for the development of inflammatory bowel disease? A meta-analysis | Q34674338 | ||
| Consumption of dairy in teenagers with and without acne | Q34677423 | ||
| Duration of oral tetracycline-class antibiotic therapy and use of topical retinoids for the treatment of acne among general practitioners (GP): A retrospective cohort study | Q34678228 | ||
| Topical spironolactone inhibits dihydrotestosterone receptors in human sebaceous glands: an autoradiographic study in subjects with acne vulgaris | Q34684140 | ||
| Retinoic acid embryopathy | Q34686260 | ||
| Isotretinoin for acne vulgaris--10 years later: a safe and successful treatment | Q34729115 | ||
| Long-term safety of spironolactone in acne: results of an 8-year followup study | Q34828649 | ||
| Milk consumption: aggravating factor of acne and promoter of chronic diseases of Western societies | Q34951913 | ||
| Efficacy and tolerability of a monophasic combined oral contraceptive containing nomegestrol acetate and 17β-oestradiol in a 24/4 regimen, in comparison to an oral contraceptive containing ethinylestradiol and drospirenone in a 21/7 regimen | Q35599735 | ||
| Effect of the glycemic index of carbohydrates on Acne vulgaris | Q35670832 | ||
| Risk factors for acute myocardial infarction in women: evidence from the Royal College of General Practitioners' oral contraception study | Q35707484 | ||
| The pathophysiology of acne vulgaris in children and adolescents, Part 1. | Q35892545 | ||
| Physical Modalities (Devices) in the Management of Acne | Q35970630 | ||
| Spironolactone and risk of incident breast cancer in women older than 55 years: retrospective, matched cohort study | Q36094069 | ||
| Light therapies for acne | Q36145236 | ||
| Nitric Oxide-Releasing Nanoparticles Prevent Propionibacterium acnes-Induced Inflammation by Both Clearing the Organism and Inhibiting Microbial Stimulation of the Innate Immune Response | Q36269182 | ||
| Laser and light-based treatments of acne and acne scarring | Q36301339 | ||
| Frequent Use of Antibiotics Is Associated with Colorectal Cancer Risk: Results of a Nested Case-Control Study | Q36426944 | ||
| Expert committee recommendations for acne management | Q36584856 | ||
| Association of pharyngitis with oral antibiotic use for the treatment of acne: a cross-sectional and prospective cohort study. | Q36903984 | ||
| Isotretinoin use and the risk of inflammatory bowel disease: a population-based cohort study. | Q37056825 | ||
| Results of a Phase 2 Efficacy and Safety Study with SB204, an Investigational Topical Nitric Oxide-releasing Drug for the Treatment of Acne Vulgaris | Q37255544 | ||
| Hormonal therapy for acne | Q37266806 | ||
| New developments in our understanding of acne pathogenesis and treatment | Q37530982 | ||
| Adverse effects of isotretinoin: A retrospective review of 1743 patients started on isotretinoin | Q37825507 | ||
| The association of acne vulgaris with diet. | Q37931819 | ||
| Oral contraceptives and venous thromboembolism: pill scares and public health. | Q37956079 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 538-549 | |
| P577 | publication date | 2018-10-05 | |
| P1433 | published in | Journal of the American Academy of Dermatology | Q15757046 |
| P1476 | title | Approaches to limit systemic antibiotic use in acne: Systemic alternatives, emerging topical therapies, dietary modification, and laser and light-based treatments | |
| P478 | volume | 80 |
Search more.